Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(7%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_3
3
21%
Ph phase_1
1
7%
Ph phase_4
4
29%
Ph not_applicable
3
21%
Ph phase_2
3
21%

Phase Distribution

1

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
3(21.4%)
Phase 4Post-market surveillance
4(28.6%)
N/ANon-phased studies
3(21.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
unknown1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.1%)
Phase 23 (21.4%)
Phase 33 (21.4%)
Phase 44 (28.6%)
N/A3 (21.4%)

Trials by Status

unknown17%
completed1179%
recruiting17%
withdrawn17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT02902198Not Applicable

Taste Physiology in Obese Volunteers Before and After Bariatric Surgery

Recruiting
NCT05682339Not Applicable

Effects of Intragastric Quinine, Alone or Combined With L-isoleucine, on Postprandial Glycaemic Control

Completed
NCT05720390Not Applicable

Effects of Intragastric Quinine, Alone or Combined With L-leucine, on Postprandial Glycaemic Control

Completed
NCT00495508Phase 4

Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy

Completed
NCT01851473Phase 1

Interactions Between Intravenous Cocaine and Acetazolamide or Quinine

Completed
NCT02276989Phase 2

Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain

Withdrawn
NCT02974348Phase 3

Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

Completed
NCT02563704Phase 3

A Trial of the Efficacy of Artesunate and Three Quinine Regimens in the Treatment of Severe Malaria in Children at the Ebolowa Regional Hospital - Cameroon

Completed
NCT02092766Phase 4

Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With Malaria

Completed
NCT01258049Phase 3

Superiority of ArTiMist Versus Quinine in Children With Severe Malaria

Completed
NCT01805232Phase 4

Intravenous Artesunate and Malaria

Unknown
NCT01047436Phase 2

Efficacy of ArTiMist™ in Children

Completed
NCT00299208Phase 2

Azithromycin Combination Therapy for Malaria

Completed
NCT00451139Phase 4

Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14